Brian Cameron

2.0k total citations
10 papers, 652 citations indexed

About

Brian Cameron is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Brian Cameron has authored 10 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Brian Cameron's work include CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (4 papers). Brian Cameron is often cited by papers focused on CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (4 papers). Brian Cameron collaborates with scholars based in United Kingdom, Ireland and United States. Brian Cameron's co-authors include Timothy J. Foster, Sharon J. Peacock, Anthony R. Berendt, Bent K. Jakobsen, Tara Mahon, Laura Douglas, Ruth Moysey, Yi Li, Steven M. Dunn and Deborah H. Sutton and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and Cancer Research.

In The Last Decade

Brian Cameron

10 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Cameron United Kingdom 8 340 250 224 181 97 10 652
Nitya S. Ramadoss United States 12 195 0.6× 367 1.5× 326 1.5× 125 0.7× 84 0.9× 29 842
Anthony L. Desbien United States 15 470 1.4× 106 0.4× 216 1.0× 194 1.1× 39 0.4× 20 738
Thomas Démoulins Switzerland 17 584 1.7× 121 0.5× 530 2.4× 150 0.8× 43 0.4× 31 948
Gustaf Lindgren Sweden 9 438 1.3× 84 0.3× 344 1.5× 239 1.3× 39 0.4× 14 761
Charles M. Stopford United States 10 369 1.1× 182 0.7× 230 1.0× 156 0.9× 22 0.2× 13 729
Peggy Farness United States 9 438 1.3× 101 0.4× 175 0.8× 110 0.6× 42 0.4× 11 679
Tilman Dumrese Germany 19 1.0k 3.0× 195 0.8× 345 1.5× 93 0.5× 82 0.8× 24 1.3k
J. Joseph Kim United States 11 263 0.8× 105 0.4× 168 0.8× 222 1.2× 33 0.3× 13 635
Clare Thompson United States 9 680 2.0× 119 0.5× 157 0.7× 98 0.5× 41 0.4× 12 836
Alp E. Oran United States 14 547 1.6× 87 0.3× 224 1.0× 180 1.0× 33 0.3× 15 860

Countries citing papers authored by Brian Cameron

Since Specialization
Citations

This map shows the geographic impact of Brian Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Cameron more than expected).

Fields of papers citing papers by Brian Cameron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Cameron. The network helps show where Brian Cameron may publish in the future.

Co-authorship network of co-authors of Brian Cameron

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Cameron. A scholar is included among the top collaborators of Brian Cameron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Cameron. Brian Cameron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bossi, Giovanna, Jane Harper, Joseph Dukes, et al.. (2015). ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing. Journal for ImmunoTherapy of Cancer. 3(S2). 3 indexed citations
2.
Hassan, Namir J., Giovanna Bossi, Katherine J. Adams, et al.. (2014). Abstract 2900: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma. Cancer Research. 74(19_Supplement). 2900–2900. 1 indexed citations
3.
Moysey, Ruth, Yi Li, Samantha Paston, et al.. (2010). High affinity soluble ILT2 receptor: a potent inhibitor of CD8+ T cell activation. Protein & Cell. 1(12). 1118–1127. 7 indexed citations
4.
Varela‐Rohena, Angel, Peter Molloy, Steven M. Dunn, et al.. (2008). Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nature Medicine. 14(12). 1390–1395. 197 indexed citations
5.
Purbhoo, Marco A., Yi Li, Deborah H. Sutton, et al.. (2007). The HLA A*0201–restricted hTERT540–548 peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor. Molecular Cancer Therapeutics. 6(7). 2081–2091. 36 indexed citations
6.
Purbhoo, Marco A., Deborah H. Sutton, Joanna E. Brewer, et al.. (2006). Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors. The Journal of Immunology. 176(12). 7308–7316. 74 indexed citations
7.
Dunn, Steven M., P.J. Rizkallah, Emma Baston, et al.. (2006). Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide‐MHC without increasing apparent cross‐reactivity. Protein Science. 15(4). 710–721. 86 indexed citations
8.
Massey, Ruth C., et al.. (2002). Functional Blocking of Staphylococcus aureus Adhesins following Growth in Ex Vivo Media. Infection and Immunity. 70(10). 5339–5345. 19 indexed citations
9.
Peacock, Sharon J., Timothy J. Foster, Brian Cameron, & Anthony R. Berendt. (1999). Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells. Microbiology. 145(12). 3477–3486. 188 indexed citations
10.
Cameron, Brian & Laura Douglas. (1996). Blood group glycolipids as epithelial cell receptors for Candida albicans. Infection and Immunity. 64(3). 891–896. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026